Approximately 16% of CD45.1+Ly6C+CD11c+MHC-II+ cells were mCherry+, indicating that these cells were able to phagocytose tumor-associated proteins and migrate to draining lymph nodes (Fig. 4K), whereby directly [18] or indirectly [36] activate effective antitumor responses. The gene discussed is ITGAX; the disease is neoplasm.